What are Matrixxs competitive advantages?
• The Zicam product brand is well established in the cough and cold remedy products market. • Matrixx is able to distinguish the benefits of Zicam Cold Remedy over competing cold remedy products by emphasizing its ability to significantly reduce the duration of the common cold; other products merely treat cold symptoms. • The Matrixx new product development model is based on creating a specialized product niche by combining proprietary application or delivery systems, like the patented Zicam gel matrix, with Class III ingredients (those already recognized by FDA under its review of OTC drugs and on the shelf in other products). This results in relatively rapid speed to market for Matrixx products compared to prescription pharmaceuticals. • Matrixx has low operational overhead, coupled with gross margins above 65%. • Matrixx has a strong management team and board of directors with extensive experience in the development, distribution and sales of over-the-counter pharmaceuticals.
